Blood Cancer News and Research

RSS
FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Scientists develop software that predicts leukemia-specific immune targets

Scientists develop software that predicts leukemia-specific immune targets

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Study finds unexpected new drug target for acute myeloid leukemia

Study finds unexpected new drug target for acute myeloid leukemia

Research shows how HLF gene affects blood cell development

Research shows how HLF gene affects blood cell development

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

New technique holds promise to screen cancer cells for drug susceptibility

New technique holds promise to screen cancer cells for drug susceptibility

Breakthrough research brings new procedure closer to helping patients with blood cancer

Breakthrough research brings new procedure closer to helping patients with blood cancer

California cracks down on weed killer as lawsuits abound

California cracks down on weed killer as lawsuits abound

FDA grants approval to first treatment for rare blood cancer

FDA grants approval to first treatment for rare blood cancer

FDA approves new drug Zelboraf for Erdheim-Chester disease

FDA approves new drug Zelboraf for Erdheim-Chester disease

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

Trial identifies genetic fault that affects treatment response in leukemia patients

Trial identifies genetic fault that affects treatment response in leukemia patients

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows